Pharmaceutical Filtration Market size will witness significant growth from 2017 to 2024.
Pharmaceutical filtration market size should experience robust growth due to rapidly growing biopharmaceutical industry. Increasing prevalence of chronic diseases such as diabetes, cardiac disorders, cancer, and arthritis have surge in demand for the development of novel and innovative sterile drugs to treat various life-threatening disorders boosting the business growth. Rising R&D investments in manufacturing large molecules, biologics and other novel drugs will drive the global pharmaceutical filtration market size. For instance, Merck has invested around USD 295 million in R&D for developing novel biopharma drugs used to treat patients with complex disorders.
Increased production of generic drugs and government mandates for sterile manufacturing and production of generic drugs will increase demand for filters and eventually fueling industry growth. Furthermore, rapid technological advancements in the filtration techniques such as nanofibers technology used in pharmaceutical industry will expand the pharmaceutical filtration market size. Huge capital requirement for research and production facilities of novel medicines, vaccines and drugs, coupled with stringent regulatory approval process for manufacturing safe, sterile and efficient drugs may hinder business growth in the future.
Get Table of Content of this Report @ https://www.gminsights.com/request-toc/upcoming/1859
Membrane filters lead the overall industry revenue share owing to the advantages offered such as presence of different membrane materials including PTFE, nylon, cellulose acetate. It allows controlled pore size distribution, greater strength and flexibility coupled with wide range of applications for solvent and air filtration. Single-use systems will grow at a rapid pace due to the low capital requirement, minimal risk of cross-contamination and higher efficiency for filtration of therapeutic drugs.
Ability to purify and fractionate particles based on size, low energy requirements, greater flexibility for separation and cost-efficiency will drive the microfiltration market over the coming few years. Nanofiltration should grow at a substantial rate owing to nanofibers application to separate large molecules from smaller ones, low pressures and minimized energy cost boosting the overall market.
Based on application, the final product processing segment is dominating the industry. Rising demand for filtration of APIs, proteins, vaccines, antibodies, and viruses will drive the segment growth. Increased production of vaccines, generic drugs and biologics boosts the manufacturing-scale segment. Increased focus on development of innovative biopharmaceuticals to treat chronic ailments will surge demand for these filtration process.
U.S. pharmaceutical filtration market will witness significant growth over the forecast period due to presence of well-established biopharma players coupled with increased investment in R&D. For instance, in 2015, the pharmaceutical research and manufacturers of America have invested around USD 58.8 billion in R&D for developing drugs desired to address the unmet medical needs of patients with chronic disorders.
Browse Full Report Details @ https://www.gminsights.com/industry-analysis/pharmaceutical-filtration-market
India and China will expand at robust growth rate in coming years due to increased investment by biopharmaceutical companies, growing prevalence of various chronic diseases and rising healthcare expenditure will propel the business demand. Moreover, increased government initiatives and funding should positively impact the industry in the coming future.
Some of the industry players in pharmaceutical filtration market include 3M, Merck, Parker Hannifin, Sartorius Stedim Biotech, Meissner, Amazon Filters, Eaton, GE Healthcare and Graver Technologies. The industry players focus on acquisitions and innovative product launch as main strategies to ensure market sustainability. In March 2017, Merck launched Express high area filters and single-use systems intended to use for filtration of high particulate level feed streams such as protein solutions and cell culture media. These filters ensure safety & efficiency of products and are cost-effective for biopharma production.